These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 29892370

  • 1. Synthesis of 4-substituted ethers of benzophenone and their antileishmanial activities.
    Arshia, Ahad F, Ghouri N, Kanwal, Khan KM, Perveen S, Choudhary MI.
    R Soc Open Sci; 2018 May; 5(5):171771. PubMed ID: 29892370
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
    Muhammad MT, Ghouri N, Khan KM, Arshia, Choudhary MI, Perveen S.
    Med Chem; 2018 May; 14(7):725-732. PubMed ID: 29332596
    [Abstract] [Full Text] [Related]

  • 3. Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.
    Hassan AA, Khalid HE, Abdalla AH, Mukhtar MM, Osman WJ, Efferth T.
    Molecules; 2022 Nov 04; 27(21):. PubMed ID: 36364404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.
    Birhan YS, Bekhit AA, Hymete A.
    Org Med Chem Lett; 2014 Dec 04; 4(1):10. PubMed ID: 26548988
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives.
    Mohammadi-Ghalehbin B, Shiran JA, Gholizadeh N, Razzaghi-Asl N.
    Mol Divers; 2023 Aug 04; 27(4):1531-1545. PubMed ID: 36001225
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.
    Istanbullu H, Bayraktar G, Karakaya G, Akbaba H, Perk NE, Cavus I, Podlipnik C, Yereli K, Ozbilgin A, Debelec Butuner B, Alptuzun V.
    Eur J Med Chem; 2023 Feb 05; 247():115049. PubMed ID: 36577215
    [Abstract] [Full Text] [Related]

  • 8. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
    Oliveira VG, Dos Santos Faiões V, Gonçalves GBR, Lima MFO, Boechat FCS, Cunha AC, de Andrade-Neto VV, de C da Silva F, Torres-Santos EC, de Souza MCBV.
    Curr Top Med Chem; 2018 Feb 05; 18(17):1454-1464. PubMed ID: 30277154
    [Abstract] [Full Text] [Related]

  • 9. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major.
    Shokri A, Emami S, Fakhar M, Teshnizi SH, Keighobadi M.
    Acta Trop; 2017 Mar 05; 167():73-78. PubMed ID: 28017860
    [Abstract] [Full Text] [Related]

  • 10. New series of 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity.
    Arshad N, Hashim J, Irfanullah, Minhas MA, Aslam J, Ashraf T, Hamid SZ, Iqbal T, Javed S.
    Bioorg Med Chem Lett; 2018 Oct 15; 28(19):3251-3254. PubMed ID: 30146096
    [Abstract] [Full Text] [Related]

  • 11. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM, Ghouri N, Perveen S, Khan KM, Choudhary MI.
    Eur J Med Chem; 2016 Jan 27; 108():13-20. PubMed ID: 26619389
    [Abstract] [Full Text] [Related]

  • 12. Antileishmanial activity of lapachol analogues.
    Lima NM, Correia CS, Leon LL, Machado GM, Madeira Mde F, Santana AE, Goulart MO.
    Mem Inst Oswaldo Cruz; 2004 Nov 27; 99(7):757-61. PubMed ID: 15654435
    [Abstract] [Full Text] [Related]

  • 13. 5-Nitroisatin-derived thiosemicarbazones: potential antileishmanial agents.
    Pervez H, Manzoor N, Yaqub M, Khan KM.
    J Enzyme Inhib Med Chem; 2014 Oct 27; 29(5):628-32. PubMed ID: 24090424
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
    Mangwegape DK, Zuma NH, Aucamp J, N'Da DD.
    Arch Pharm (Weinheim); 2021 May 27; 354(5):e2000280. PubMed ID: 33491807
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and In vitro Leishmanicidal Activities of Six Quercetin Derivatives.
    Mohajeri M, Saghaei L, Ghanadian M, Saberi S, Pestechian N, Ostadhusseini E.
    Adv Biomed Res; 2018 May 27; 7():64. PubMed ID: 29862213
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands.
    Sheikhmoradi V, Saberi S, Saghaei L, Pestehchian N, Fassihi A.
    Res Pharm Sci; 2018 Apr 27; 13(2):111-120. PubMed ID: 29606965
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the in vitro antileishmanial activities of bioactive guided fractionations of two medicinal plants.
    Al Nasr IS.
    Trop Biomed; 2020 Mar 01; 37(1):15-23. PubMed ID: 33612714
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
    Chandra N, Pandey S, Ramesh, Suryawanshi SN, Gupta S.
    Eur J Med Chem; 2006 Jun 01; 41(6):779-85. PubMed ID: 16697490
    [Abstract] [Full Text] [Related]

  • 19. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
    Corman HN, Ross JN, Fields FR, Shoue DA, McDowell MA, Lee SW.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0265822. PubMed ID: 36342284
    [Abstract] [Full Text] [Related]

  • 20. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
    da Trindade Granato J, Dos Santos JA, Calixto SL, Prado da Silva N, da Silva Martins J, da Silva AD, Coimbra ES.
    Biomed Pharmacother; 2018 Oct 21; 106():1082-1090. PubMed ID: 30119174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.